Substance misuse disorder in Saudi Arabia: A comprehensive examination of current demographic patterns, trends, and intervention requirements
Drug-related challenges persist in Saudi Arabia; however, because of limited data from recent epidemiological studies on drug disorders, the full extent is unknown. Saudi Arabia is unique because it as an Islamic country with strict regulations against drug trafficking and a religious prohibition on drugs and alcohol, which contributes to distinct trends in substance misuse disorder (SMD). Although some aspects mirror global patterns, others exhibit regional characteristics specific to the country. Despite data variability, actionable recommendations have emerged for SMD prevention and treatment. During the COVID-19 pandemic, a high number of reports was evident; however, SMD publications often reiterate old findings and overlook emerging psychoactive substances (EPS), such as 'Shabu", pregabalin, and benzodiazepines. Further studies are needed, including educational initiatives, national surveys, stricter drug regulations, and an early warning system for traditional SMD and EPS.
Authors
- Ahmed I. Al‐Asmari (ORCID: https://orcid.org/0000-0002-4488-2194)
- Mansour Tobaiqy (ORCID: https://orcid.org/0000-0002-4292-0900)
Institutions
- King Faisal Specialist Hospital & Research Centre (SA)
- University of Jeddah (SA)
Publication Details
- Journal
- Saudi Pharmaceutical Journal
- Published
- 2024-08-16
- DOI
- https://doi.org/10.1016/j.jsps.2024.102163
- Citations
- 11
- Primary Topic
- Substance Abuse Treatment and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 4.25